Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Patients with Melanoma
Neurol 101:e2472-e2482, Pepys,J.,et al, 2023
See this aricle in Pubmed

Article Abstract
N-irAEs are a relatively common complication if ICIs (8% of our cohort). Older age was not associated with its development or severity, in contrast with non-n-irAEs which occurred less frequently in the elderly population. Rechallenge did not result in life-threatening AEs. Development of any irAEs was associated with longer survival; this association was stronger with n-irAEs.
 
Related Tags
(click to filter results - removes previous filter)

adverse drug reaction
complications
immune checkpoint inhibitors
immune effector cell-associated neurotoxicity syndrome
immune-related adverse events
incidence
melanoma,malignant
prognosis
rechallenge

Click Here to return To Results